Biofeedback for Second Stage of Labor

November 28, 2022 updated by: Eran Brazilay, MD PhD, Assuta Ashdod Hospital

Ultrasound Imaging Biofeedback for Shortening the Second Stage of Labor: a Randomized Prospective Study

The purpose of this study is to examine whether transperineal ultrasound as visual biofeedback can be used during labor as an effective tool for shortening the second stage of labor and reducing the need for instrumental delivery, in a prospective randomized design.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Biofeedback provides patients with better control of their body and their physiological reactions respective of the examined process, such as stress/anxiety, sports activity, labor, etc.

Women under epidural anesthesia, may frequently feel lack of control over the birthing process and difficulty in bearing down effectively, which is a very significant part of the second stage of labor.

Transperineal ultrasound during labor is a standard procedure in many medical centers in the world, mainly used to assist obstetricians in evaluating the progress of labor, fetal head position and assessing the chances of successful operative delivery. One of the most common tools used in transperineal ultrasound in measurement of the angle of progression, which has been suggested as a subjective method for assessing fetal station and for predicting successful vaginal delivery. A preliminary non-randomized study raised the possibility that the use of transperineal ultrasound during labor as a biofeedback tool may shorten the second stage of labor.

The purpose of this study is to examine whether this tool can be used during labor as an effective tool for shortening the second stage of labor and reducing the need for instrumental delivery, in a prospective randomized design.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ashdod, Israel
        • Assuta Ashdod Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. First labor
  2. Full dilation
  3. Head position between SP-1 and SP+2.
  4. Epidural anesthesia
  5. No contraindication for vaginal delivery
  6. Parturient informed consent

Exclusion Criteria:

  1. Participation in parallel studies.
  2. Category III fetal monitoring requiring immediate delivery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Biofeedback
The patient will be instructed to bear down during 4 consecutive contractions while monitoring head descent using transperineal ultrasound. In the study group, patients will observe the descent of the head during contraction on the ultrasound display screen.
Patient will observe the descent of the fetal head as they push during contractions
No Intervention: Control
The patient will be instructed to bear down during 4 consecutive contractions while monitoring head descent using transperineal ultrasound. In the control group, patients will not observe the ultrasound display screen.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of the second stage of labor
Time Frame: Up to 6 hours
Minutes from first documentation of full dilatation to delivery.
Up to 6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mode of delivery
Time Frame: Up to 6 hours
Mode of delivery (categorical): spontaneous vaginal, operative vaginal or cesarean
Up to 6 hours
Neonatal 1 minute Apgar score
Time Frame: Up to 6 hours
Apgar score at 1 minute after delivery (scale of 0-10)
Up to 6 hours
Neonatal 5 minute Apgar score
Time Frame: Up to 6 hours
Apgar score at 5 minute after delivery (scale of 0-10)
Up to 6 hours
Cord pH
Time Frame: Up to 6 hours
Umbilical cord blood pH
Up to 6 hours
Postpartum hemorrhage
Time Frame: Up to 24 hours
Rate of early postpartum hemorrhage (during first 24 hours)
Up to 24 hours
Maternal perineal tears
Time Frame: Up to 6 hours
Maternal perineal tear grade (categorical): None and grades 1-4
Up to 6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eran Barzilay, MD PhD, Samson Assuta Ashdod University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2020

Primary Completion (Actual)

November 19, 2022

Study Completion (Actual)

November 25, 2022

Study Registration Dates

First Submitted

December 15, 2019

First Submitted That Met QC Criteria

December 22, 2019

First Posted (Actual)

December 26, 2019

Study Record Updates

Last Update Posted (Actual)

November 30, 2022

Last Update Submitted That Met QC Criteria

November 28, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Long

Clinical Trials on Visual biofeedback

3
Subscribe